Scientists breed 'made-to-measure' molecular 'furs' on surfaces, with the individual 'hairs' consisting of peptides, short proteins. These peptides control the biocompatibility, i.e. which proteins adsorb.
The TECNALIA Technological Corporation is taking part in the Cenit Intelimplant project, the goal of which is to develop advanced biomaterials based on innovative technologies (microtechnologies, nanotechnologies, tissue and surface engineering) for the manufacture of a new generation of implants which have greater durability and reliability, need less recuperation time and that provide data on their state and progress.
There is an urgent need for more testing, extending existing governance arrangements and creating new arrangements for the control of the rapidly developing field of nanomaterials, according to a report by the influential Royal Commission on Environmental Pollution.
The international summit of the world's leaders in nanofibers - Nanofibers for the 3rd Millennium - NANO FOR LIFE organized in the cooperation of Elmarco Ltd., Technical University in Liberec, North Carolina State University and Institute of Experimental Medicine AS CR, will take place on 11th and 12th March 2009 in Prague, Czech Republic.
The Chemical Heritage Foundation's 'Molecule that Matters' exhibition and lecture series is more than half way through its run. The exhibition showcases 10 organic molecules that profoundly altered our world: aspirin, isooctane, penicillin, polyethylene, nylon, DNA, progestin, DDT, Prozac, and buckminsterfullerene. The exhibit connects each molecule to one decade of the 20th century.
The analysis of nanotechnology coverage in German print media was the subject of a research project conducted by the Federal Institute for Risk Assessment (BfR). The results: In the media coverage nanotechnology is not presented as a risk technology; most articles stress the benefits of this new technology.
On October 27th-31st 2008 'The First School of Metrology and Standardization in Nanotechnologies, Nanoindustry and Nanomaterials' was conducted by the Russian Corporation of Nanotechnologies (RUSNANO) together with the Federal Agency for Technical Regulating and Metrology.
The supervisory council of the Russian Corporation of Nanotechnologies (RUSNANO) recommended the board of directors to approve the investment in a medical project aimed at the development, design and building of high technological scientific and industrial beta complexes for the production of medical technology.
The Cancer Advanced-Technology Team that is developing an imaging system to limit the spread and/or reccurrence of that disease has been named the winner of CIMIT?s annual Edward M. Kennedy Award for Healthcare Innovation.